{
  "protocolSection": {
    "identificationModule": {
      "nctId": "NCT01996423",
      "orgStudyIdInfo": {
        "id": "12-185"
      },
      "secondaryIdInfos": [
        {
          "id": "1130615",
          "type": "OTHER_GRANT",
          "domain": "FONDECYT"
        }
      ],
      "organization": {
        "fullName": "Pontificia Universidad Catolica de Chile",
        "class": "OTHER"
      },
      "briefTitle": "Impact of Vitamin D Supplementation on Severity of Pediatric Atopic Dermatitis",
      "officialTitle": "Impact of Vitamin D Supplementation on Clinical Severity and Immunologic Tolerance of Pediatric Atopic Dermatitis",
      "acronym": "VIDATOPIC"
    },
    "statusModule": {
      "statusVerifiedDate": "2015-02",
      "overallStatus": "COMPLETED",
      "expandedAccessInfo": {
        "hasExpandedAccess": false
      },
      "startDateStruct": {
        "date": "2014-04"
      },
      "primaryCompletionDateStruct": {
        "date": "2014-12",
        "type": "ACTUAL"
      },
      "completionDateStruct": {
        "date": "2014-12",
        "type": "ACTUAL"
      },
      "studyFirstSubmitDate": "2013-11-11",
      "studyFirstSubmitQcDate": "2013-11-21",
      "studyFirstPostDateStruct": {
        "date": "2013-11-27",
        "type": "ESTIMATED"
      },
      "lastUpdateSubmitDate": "2015-02-28",
      "lastUpdatePostDateStruct": {
        "date": "2015-03-03",
        "type": "ESTIMATED"
      }
    },
    "sponsorCollaboratorsModule": {
      "responsibleParty": {
        "type": "SPONSOR"
      },
      "leadSponsor": {
        "name": "Pontificia Universidad Catolica de Chile",
        "class": "OTHER"
      }
    },
    "oversightModule": {
      "oversightHasDmc": false
    },
    "descriptionModule": {
      "briefSummary": "The purpose of this study is to determine whether oral vitamin D supplementation improves the clinical severity of atopic dermatitis in children. In addition, this study plans to evaluate the effects of vitamin D supplementation on several key aspects of the immune system of children with atopic dermatitis."
    },
    "conditionsModule": {
      "conditions": [
        "Atopic Dermatitis"
      ],
      "keywords": [
        "Atopic dermatitis",
        "vitamin D"
      ]
    },
    "designModule": {
      "studyType": "INTERVENTIONAL",
      "phases": [
        "NA"
      ],
      "designInfo": {
        "allocation": "RANDOMIZED",
        "interventionModel": "PARALLEL",
        "primaryPurpose": "TREATMENT",
        "maskingInfo": {
          "masking": "QUADRUPLE",
          "whoMasked": [
            "PARTICIPANT",
            "CARE_PROVIDER",
            "INVESTIGATOR",
            "OUTCOMES_ASSESSOR"
          ]
        }
      },
      "enrollmentInfo": {
        "count": 101,
        "type": "ACTUAL"
      }
    },
    "armsInterventionsModule": {
      "armGroups": [
        {
          "label": "Vitamin D3 supplementation",
          "type": "EXPERIMENTAL",
          "description": "Subjects in the experimental arm will receive weekly vitamin D3 doses in oral suspension during 6 weeks. Weekly dose varies according to age group: VD3 8000 IU between ages 2-5.9 years, VD3 12000 IU between ages 6-11.9 years, VD3 16000 IU between ages 12-17.9 years.",
          "interventionNames": [
            "Dietary Supplement: Vitamin D3"
          ]
        },
        {
          "label": "Placebo",
          "type": "PLACEBO_COMPARATOR",
          "description": "Subjects in the placebo arm will receive weekly placebo oral suspension during 6 weeks.",
          "interventionNames": [
            "Dietary Supplement: Placebo"
          ]
        }
      ],
      "interventions": [
        {
          "type": "DIETARY_SUPPLEMENT",
          "name": "Vitamin D3",
          "armGroupLabels": [
            "Vitamin D3 supplementation"
          ],
          "otherNames": [
            "Cholecalciferol"
          ]
        },
        {
          "type": "DIETARY_SUPPLEMENT",
          "name": "Placebo",
          "armGroupLabels": [
            "Placebo"
          ]
        }
      ]
    },
    "outcomesModule": {
      "primaryOutcomes": [
        {
          "measure": "Change in SCORAD index",
          "description": "Change in Scoring Atopic Dermatitis (SCORAD) index after 6 weeks of vitamin D3 (VD3) supplementation or placebo in children with atopic dermatitis.",
          "timeFrame": "baseline and 6 weeks"
        }
      ],
      "secondaryOutcomes": [
        {
          "measure": "Changes in Th2 immunity",
          "description": "Eosinophil blood counts, serum IgE, Th2 lymphocytes among stimulated PBMCs, serum CCL17, CCL22, and CCL27.",
          "timeFrame": "baseline and 6 weeks"
        },
        {
          "measure": "Change in dendritic cell-mediated tolerance and regulatory T cells",
          "description": "Number and phenotype of blood dendritic cells and number of regulatory T cells.",
          "timeFrame": "baseline and 6 weeks"
        },
        {
          "measure": "Effect of VD3 supplementation on immunity to Staphylococcus aureus",
          "description": "Serum cathelicidin levels, S. aureus skin carriage, and specific IgE to staphylococcal enterotoxins.",
          "timeFrame": "baseline and 6 weeks"
        },
        {
          "measure": "Vitamin D receptor single nucleotide polymorphisms",
          "description": "Effect of VDR SNPs on the VD3 response.",
          "timeFrame": "baseline and 6 weeks"
        },
        {
          "measure": "Change in epidermal protein expression",
          "description": "Gene expression of epidermal proteins by PCR obtained from lesional and non-lesional tape stripping samples.",
          "timeFrame": "6 weeks"
        }
      ],
      "otherOutcomes": [
        {
          "measure": "Number of participants with adverse events",
          "description": "Adverse events of atopic dermatitis patients with VD3 and placebo",
          "timeFrame": "6 weeks"
        }
      ]
    },
    "eligibilityModule": {
      "eligibilityCriteria": "Inclusion Criteria:\n\n* Atopic dermatitis diagnosed according to Hanifin and Rajka criteria\n* Age 2 - 17 years\n* SCORAD 10 - 103\n\nExclusion Criteria:\n\n* Active skin infection\n* History of underlying illness causing immunosuppression within the past 2 years\n* Immunosuppressors taken within the past month\n* Parathyroid disease\n* Sarcoidosis\n* Acute or chronic renal disease\n* Hyper or hypocalcemia\n* Thyroid disease\n* Osteomalacia or Paget's disease of bone\n* Malabsorption\n* Use of VD supplements (\\> 400 IU daily) or fish oil supplements in the past month\n* Treatment for known VD deficiency in the last 6 months\n* Treatment with moderate or high potency topical corticosteroids, oral or topical antibiotics, oral antivirals, immune enhancers, or topical calcineurin inhibitors in the past 7 days\n* Phototherapy in the past month\n* Autoimmune disease or immunodeficiency\n* Planned trip to sunny climate during the 6-week study.",
      "healthyVolunteers": false,
      "sex": "ALL",
      "minimumAge": "2 Years",
      "maximumAge": "17 Years",
      "stdAges": [
        "CHILD"
      ]
    },
    "contactsLocationsModule": {
      "overallOfficials": [
        {
          "name": "Arturo Borzutzky, M.D.",
          "affiliation": "School of Medicine, Pontificia Universidad Católica de Chile",
          "role": "PRINCIPAL_INVESTIGATOR"
        },
        {
          "name": "Carlos A Camargo Jr., M.D., DrPH",
          "affiliation": "Massachusetts General Hospital, Harvard University, Boston, USA",
          "role": "STUDY_DIRECTOR"
        },
        {
          "name": "Cristian Vera, M.D.",
          "affiliation": "School of Medicine, Pontificia Universidad Católica de Chile",
          "role": "STUDY_DIRECTOR"
        },
        {
          "name": "Lorena Cifuentes, M.D.",
          "affiliation": "School of Medicine, Pontificia Universidad Católica de Chile",
          "role": "STUDY_DIRECTOR"
        },
        {
          "name": "Sergio Silva, M.D.",
          "affiliation": "School of Medicine, Pontificia Universidad Católica de Chile",
          "role": "STUDY_DIRECTOR"
        }
      ],
      "locations": [
        {
          "facility": "School of Medicine, Pontificia Universidad Católica de Chile",
          "city": "Santiago",
          "country": "Chile",
          "geoPoint": {
            "lat": -33.45694,
            "lon": -70.64827
          }
        }
      ]
    },
    "referencesModule": {
      "references": [
        {
          "pmid": "38483248",
          "type": "DERIVED",
          "citation": "Borzutzky A, Iturriaga C, Perez-Mateluna G, Cristi F, Cifuentes L, Silva-Valenzuela S, Vera-Kellet C, Cabalin C, Hoyos-Bachiloglu R, Navarrete-Dechent C, Cossio ML, Le Roy C, Camargo CA Jr. Effect of weekly vitamin D supplementation on the severity of atopic dermatitis and type 2 immunity biomarkers in children: A randomized controlled trial. J Eur Acad Dermatol Venereol. 2024 Sep;38(9):1760-1768. doi: 10.1111/jdv.19959. Epub 2024 Mar 14."
        }
      ]
    }
  },
  "derivedSection": {
    "miscInfoModule": {
      "versionHolder": "2026-02-04"
    },
    "conditionBrowseModule": {
      "meshes": [
        {
          "id": "D003876",
          "term": "Dermatitis, Atopic"
        }
      ],
      "ancestors": [
        {
          "id": "D012873",
          "term": "Skin Diseases, Genetic"
        },
        {
          "id": "D030342",
          "term": "Genetic Diseases, Inborn"
        },
        {
          "id": "D009358",
          "term": "Congenital, Hereditary, and Neonatal Diseases and Abnormalities"
        },
        {
          "id": "D003872",
          "term": "Dermatitis"
        },
        {
          "id": "D012871",
          "term": "Skin Diseases"
        },
        {
          "id": "D017437",
          "term": "Skin and Connective Tissue Diseases"
        },
        {
          "id": "D017443",
          "term": "Skin Diseases, Eczematous"
        },
        {
          "id": "D006969",
          "term": "Hypersensitivity, Immediate"
        },
        {
          "id": "D006967",
          "term": "Hypersensitivity"
        },
        {
          "id": "D007154",
          "term": "Immune System Diseases"
        }
      ]
    },
    "interventionBrowseModule": {
      "meshes": [
        {
          "id": "D002762",
          "term": "Cholecalciferol"
        }
      ],
      "ancestors": [
        {
          "id": "D002782",
          "term": "Cholestenes"
        },
        {
          "id": "D002776",
          "term": "Cholestanes"
        },
        {
          "id": "D013256",
          "term": "Steroids"
        },
        {
          "id": "D000072473",
          "term": "Fused-Ring Compounds"
        },
        {
          "id": "D011083",
          "term": "Polycyclic Compounds"
        },
        {
          "id": "D013261",
          "term": "Sterols"
        },
        {
          "id": "D014807",
          "term": "Vitamin D"
        },
        {
          "id": "D012632",
          "term": "Secosteroids"
        },
        {
          "id": "D008563",
          "term": "Membrane Lipids"
        },
        {
          "id": "D008055",
          "term": "Lipids"
        }
      ]
    }
  },
  "hasResults": false
}